Variant report
Variant | esv3365356 |
---|---|
Chromosome Location | chr2:56740148-56747546 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559652807 | chr2:56742206-56742207 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
2 | rs190410975 | chr2:56742290-56742291 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182936732 | chr2:56742366-56742367 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
4 | rs188663690 | chr2:56742381-56742382 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568166921 | chr2:56742429-56742430 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs530927039 | chr2:56742430-56742431 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538201743 | chr2:56742471-56742472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs550725283 | chr2:56742487-56742488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs558274341 | chr2:56742501-56742502 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs890098 | chr2:56742568-56742569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs539656103 | chr2:56742571-56742572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs578032845 | chr2:56742602-56742603 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193255775 | chr2:56742609-56742610 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs143156706 | chr2:56742626-56742627 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs535393991 | chr2:56742646-56742647 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555410668 | chr2:56742662-56742663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs575264735 | chr2:56742747-56742748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537565235 | chr2:56742751-56742752 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs557860415 | chr2:56742783-56742784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs577349207 | chr2:56742797-56742798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs546026718 | chr2:56742808-56742809 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
22 | rs539080596 | chr2:56742825-56742826 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
23 | rs559612920 | chr2:56742832-56742833 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
24 | rs73940703 | chr2:56742845-56742846 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs546009965 | chr2:56742894-56742895 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146770914 | chr2:56742908-56742909 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
27 | rs111462514 | chr2:56742917-56742918 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs182381801 | chr2:56742918-56742919 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs530966524 | chr2:56742990-56742991 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs550783264 | chr2:56742995-56742996 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187823347 | chr2:56743015-56743016 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs10209533 | chr2:56743021-56743022 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs546821391 | chr2:56743036-56743037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs74473980 | chr2:56743050-56743051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs17048041 | chr2:56743065-56743066 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs191599203 | chr2:56743082-56743083 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs548970404 | chr2:56743091-56743092 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs184073726 | chr2:56743099-56743100 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs17048045 | chr2:56743132-56743133 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs557557458 | chr2:56743144-56743145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs561599279 | chr2:56743152-56743153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs35330805 | chr2:56743160-56743161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs17048048 | chr2:56743166-56743167 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs10164843 | chr2:56743178-56743179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs73940704 | chr2:56743213-56743214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs188799953 | chr2:56743227-56743228 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs573175793 | chr2:56743234-56743235 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs542098441 | chr2:56743247-56743248 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs562442143 | chr2:56743296-56743297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs113637414 | chr2:56743298-56743299 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Developmental delay | 21147756 | CNVD |
Mental retardation | 19951919 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Microcephaly | 20799320 | CNVD |
camptodactyly | 20799320 | CNVD |
cognitive delay | 20799320 | CNVD |
prenatal and postnatal growth deficiency | 20799320 | CNVD |
ptosis of eyelids | 20799320 | CNVD |
Maculopathy | 20981449 | CNVD |
2p16.1 microdeletion syndrome | 22283845 | CNVD |
Autism | 22579565 | CNVD |
Autism | 16963482 | CNVD |
Autism | 21750575 | CNVD |
idiopathic intellectual disability | 16963482 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Follicular lymphoma | 17699855 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:56742200-56742400 | Bivalent Enhancer | Fetal Heart | heart |
2 | chr2:56742200-56742800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr2:56742200-56743400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr2:56742800-56743000 | Bivalent Enhancer | Fetal Heart | heart |
5 | chr2:56743400-56745800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
6 | chr2:56745800-56746000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr2:56746000-56746600 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
8 | chr2:56746600-56749600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr2:56746800-56747800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr2:56747000-56747400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr2:56747000-56747400 | Enhancers | HSMM | muscle |
12 | chr2:56747200-56748000 | Enhancers | Adipose Nuclei | Adipose |
13 | chr2:56747400-56749600 | Weak transcription | HSMM | muscle |
14 | chr2:56747400-56749800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |